You are here: Industry Insights > breast

News List

LPG SYSTEMS Unveils a Major Advancement: Irradiated Mastectomy Patients Can Benefit From Minimally Invasive Breast Reconstruction En-CPhI.CN
December 10, 2019
A pilot study published in the Breast Journal shows the benefits of using Endermologie - a trademark of LPG SYSTEMS - in breast reconstruction after mastectomy and radiotherapy.
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy En-CPhI.CN
October 10, 2019
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer.
Study finds onion and garlic consumption may reduce breast cancer risk worldpharmanews
September 24, 2019
Onions and garlic are key ingredients in sofrito, a condiment that's a staple of Puerto Rican cuisine. They may also be a recipe for reducing the risk of breast cancer.
Higher Mortality Seen for Male Breast Cancer Patients drugs
September 24, 2019
Male breast cancer patients have higher mortality after cancer diagnosis than female patients, according to a study published online Sept. 19 in JAMA Oncology.
Full Chemo Doses May Improve Survival in Breast Cancer drugs
September 12, 2019
Maintaining full doses of chemotherapy, especially early in the treatment course, is important for survival of intermediate or high-risk breast cancer patients...
Scientists Find Biological Link Between High Blood Pressure and Breast Cancer drugs
September 09, 2019
Researchers have identified a protein that may be a risk factor for both high blood pressure and breast cancer.
USPSTF Advises Meds to Reduce Risk for Primary Breast Cancer drugs
September 04, 2019
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians offer risk-reducing medications to women at increased risk for breast cancer and at low risk for adverse medication effects.
EC approves Roche’s Tecentriq combination to treat breast cancer pharmaceutical-technology
September 03, 2019
Roche has gained approval from the European Commission (EC) for Tecentriq (atezolizumab) with chemotherapy (Abraxane) to treat patients with unresectable locally advanced or...
Breast cancer can form 'sleeper cells' after drug treatment worldpharmanews
September 03, 2019
Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life years after initial treatment.
Type and Timing of Menopausal HRT Affect Risk of Breast Cancer drugs
September 02, 2019
Use of menopausal hormone therapy (MHT) is associated with increased incidence of breast cancer, according to a study published online in The Lancet.

Previous page 1 2 3 4 5 6 Next page